Categories Side Effects


Relevance: Medium-High
Most relevant for: People with breast cancer or metastatic breast cancer in sexual or intimate relationships and their partners
Topic: Sex and intimacy after breast cancer
A breast cancer diagnosis and treatment can affect relationships with romantic partners. This review highlights two studies that looked at how people with breast cancer and their partners are affected, how they cope, how best to communicate with each other and how to talk with healthcare providers about concerns related to cancer and sexuality. (Posted 8/8/23)
Este artículo está disponible en español.
READ MORE ›

Relevance: High
Most relevant for: People with early-stage breast cancer who are post-menopausal
Study: Treatment to reduce bone fractures also improves breast cancer survival in postmenopausal people
A large study looked at the effects of adding the bone-protective drug denosumab (Prolia), to standard hormone therapy for the treatment of early-stage, postmenopausal, HR-positive breast cancer. The researchers found that adding denosumab to aromatase inhibitor hormonal therapy improved bone health, disease-free survival and overall survival. (Posted 2/27/23)
Este artículo está disponible en español.
READ MORE ›

Relevance: Medium-High
Most relevant for: People currently undergoing treatment for cancer
Guideline: Guidelines on exercise, diet, and weight during cancer treatment
Most professional guidelines on exercise, diet and weight management have focused on the health of the general population and cancer survivors. The American Society of Clinical Oncology (ASCO) has now published evidence-based recommendations for exercise, diet and weight specifically for people who are in active treatment for cancer. (Posted 11/29/22) Este artículo está disponible en español.
READ MORE ›

Relevance: Medium-High
Most relevant for: People taking a PARP inhibitor for ovarian cancer maintenance therapy
Study: More is not better: PARP dose can be safely reduced for people with ovarian cancer
Maintenance therapy with a PARP inhibitor is now the standard of care for many people with advanced or recurrent ovarian cancer. However, PARP inhibitors may have significant side effects. This study shows that reducing the dose of a PARP inhibitor does not affect survival. (Posted 11/8/22)
Este artículo está disponible en español.
READ MORE ›

Relevance: High
Most relevant for: People with pancreatic cancer who are dealing with related pain.
Update: Strategies for managing pancreatic cancer pain
Abdominal pain is often a severe, ongoing symptom of pancreatic cancer, yet little research has been done on how to best reduce this pain. The authors of this review discuss current strategies for managing cancer-related pain and their effectiveness. (Posted 10/31/22)
Este artículo está disponible en español.
READ MORE ›

Relevance: High
Most relevant for: People considering acupuncture for managing breast cancer treatment symptoms.
Study: Acupuncture may ease breast cancer treatment side effects
Acupuncture can ease some symptoms of breast cancer treatment. Multiple studies found that acupuncture is a safe and effective strategy to manage certain symptoms but also called for more rigorous research on the topic. (Posted 9/28/22) Este artículo está disponible en español.
READ MORE ›

Relevance: Medium
Most relevant for: People with breast implants
Update: FDA reports on new cancers linked to breast implants
New cancers have been found in women with both textured and smooth implants that are filled with either saline or silicone. These cancers are extremely rare. The FDA has reported cases of a type of skin cancer and blood cancers in the scar tissue that forms around breast implants. The newly reported lymphomas are different from the previously reported breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). (Posted 9/27/22). Este artículo está disponible en español.
READ MORE ›

Relevance: Medium-High
Most relevant for: People with metastatic castration resistant prostate cancer who have an inherited or tumor mutation in BRCA2.
Study: PARP inhibitor treatment for metastatic prostate cancer shows most benefit in men with inherited BRCA mutations
This study looked at the benefit of using the PARP inhibitor niraparib to treat metastatic castration-resistant prostate cancer (mCRPC). Participants included those with an inherited or tumor mutation in BRCA1 or BRCA2 or an inherited or tumor mutation in another gene that affects DNA repair. Participants with an inherited or tumor mutation in BRCA1 or BRCA2 had better survival compared to those without a BRCA mutation. Side effects from niraparib were common, and consistent with previous reports for PARP inhibitors. (posted 9/6/2022)
Este artículo está disponible en español.
READ MORE ›

Relevance: Medium-High
Most relevant for: Cancer patients who are experiencing fatigue related to cancer or its treatment.
Study: Physical activity may decrease fatigue associated with cancer treatment
Many cancer survivors experience fatigue during and after they complete treatment. This study looked at the effect of home-based physical activity on fatigue in cancer survivors. It also looked at whether frequent counseling encouraged people to start and continue their exercise routines. (Posted 8/1/22). Este artículo está disponible en español.
READ MORE ›

Relevance: High
Most relevant for: People who are experiencing side effects due to cancer treatment or cancer.
Study: The hidden financial burden of treating cancer care symptoms
Drugs commonly used to treat symptoms of cancer and cancer treatment side effects can cost thousands of dollars out of pocket for patients, depending on what drugs are used. (Posted 6/29/2022). Este artículo está disponible en español.
READ MORE ›